Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Protein-lysine N-methyltransferase that monomethylates both histones and non-histone proteins. Additionally we are shipping SETD8 Proteins (9) and many more products for this protein.
Showing 10 out of 120 products:
Human Monoclonal SETD8 Primary Antibody for IF, IHC (p) - ABIN387779
Song, Zheng, Liu, Wei, Dai, Zhang, Calin, Hao, Wei, Zhang, Chen: An miR-502-binding site single-nucleotide polymorphism in the 3'-untranslated region of the SET8 gene is associated with early age of breast cancer onset. in Clinical cancer research : an official journal of the American Association for Cancer Research 2009
Show all 5 references for ABIN387779
Human Monoclonal SETD8 Primary Antibody for WB - ABIN387780
Zhang, Bruice: Product specificity and mechanism of protein lysine methyltransferases: insights from the histone lysine methyltransferase SET8. in Biochemistry 2010
Show all 5 references for ABIN387780
Human Polyclonal SETD8 Primary Antibody for EIA, WB - ABIN453371
Kalakonda, Fischle, Boccuni, Gurvich, Hoya-Arias, Zhao, Miyata, Macgrogan, Zhang, Sims, Rice, Nimer: Histone H4 lysine 20 monomethylation promotes transcriptional repression by L3MBTL1. in Oncogene 2008
Show all 2 references for ABIN453371
Human Polyclonal SETD8 Primary Antibody for FACS, IHC (p) - ABIN390472
Houston, McManus, Adams, Sims, Carpenter, Hendzel, Rice: Catalytic function of the PR-Set7 histone H4 lysine 20 monomethyltransferase is essential for mitotic entry and genomic stability. in The Journal of biological chemistry 2008
Show all 2 references for ABIN390472
Human Polyclonal SETD8 Primary Antibody for EIA, WB - ABIN356688
Nishioka, Rice, Sarma, Erdjument-Bromage, Werner, Wang, Chuikov, Valenzuela, Tempst, Steward, Lis, Allis, Reinberg: PR-Set7 is a nucleosome-specific methyltransferase that modifies lysine 20 of histone H4 and is associated with silent chromatin. in Molecular cell 2002
Show all 2 references for ABIN356688
Human Polyclonal SETD8 Primary Antibody for EIA, IHC (p) - ABIN356687
Fang, Feng, Ketel, Wang, Cao, Xia, Erdjument-Bromage, Tempst, Simon, Zhang: Purification and functional characterization of SET8, a nucleosomal histone H4-lysine 20-specific methyltransferase. in Current biology : CB 2002
Show all 2 references for ABIN356687
SET8 expression is associated with overall survival in gastric cancer
analysis of a structural model for how Set8 uses multivalent interactions to bind and methylate the nucleosome based on crystallographic and solution studies of the Set8/nucleosome complex
This study showed SCF (show KITLG Antibodies)(beta-TRCP (show BTRC Antibodies)) earmarks Set8 for ubiquitination and degradation in a casein kinase I (show CSNK1D Antibodies)-dependent manner, which is activated by DNA-damaging agents.
Overall, the results revealed that miR (show MLXIP Antibodies)-127-3p acts as a tumor suppressor and that its down-regulation in cancer may contribute to OS progression and metastasis.
commonality of SPS8I1-3 against SETD8, together with their distinct structures and mechanisms for SETD8 inhibition, argues for the collective application of these compounds as SETD8 inhibitors
SET8 is required for 53BP1 (show TP53BP1 Antibodies) recruitment and efficient repair of DSB.
These data suggest that there are significant associations between the miR (show MLXIP Antibodies)-502-binding site single nucleotide polymorphism in the 3'-UTR (show UTS2R Antibodies) of SET8 and the TP53 (show TP53 Antibodies) codon 72 polymorphism with cervical cancer in Chinese, and there is a gene-gene interaction.
Our results demonstrated that SETD8 rs16917496 C/T polymorphism was associated with decreased risk of developing pediatric acute lymphoblastic leukemia
The SNP in the miR502 binding site of the SET8 3'-untranslated region seems to influence survival of non-Hodgkin's lymphoma.
significant association between the polymorphism (rs16917496) of the miR (show MLXIP Antibodies)-502-binding site in the 3'-UTR (show UTS2R Antibodies) of SET8 and TP53 (show TP53 Antibodies) codon 72 polymorphism and the risk of developing NSCLC.
PR-Set7 is a direct target of Cul4A (show CUL4A Antibodies) for degradation and involved in the formation of lung tumors in the conditional Cul4A (show CUL4A Antibodies) transgenic mouse model.
These results suggest that Setd8 is an important regulator of erythroid maturation that works in part through repression of Gata2 (show GATA2 Antibodies) expression.
These results establish SetD8 as a determinant of erythroid cell maturation and provide a framework for understanding how a broadly expressed histone-modifying enzyme mediates cell-type-specific GATA factor function.
all of the H3K36-specific methyltransferases, including ASH1L (show ASH1L Antibodies), HYPB (show SETD2 Antibodies), NSD1 (show NSD1 Antibodies), and NSD2 (show WHSC1 Antibodies) were inhibited by ubH2A, whereas the other histone methyltransferases, including PRC2, G9a (show EHMT2 Antibodies), and Pr-Set7 were not affected by ubH2A.
Data indicate a vital link between GATA-1 (show GATA1 Antibodies) and the histone H4 (show HIST1H4H Antibodies) lysine 20 methyltransferase PR-Set7/SetD8 (SetD8).
Pr-set7 knockdown caused increased gammaH2AX (show H2AFX Antibodies) foci on chromosomes indicating DNA damage on chromosomes.
Setd8 is a crucial inhibitor of apoptosis in skin and its activity is essential for epidermal stem cell survival, proliferation and differentiation
the SET8 and PCNA (show PCNA Antibodies) interaction couples H4-K20 (show KRT20 Antibodies) methylation with DNA replication
PR-Set7 enzymatic activity is essential for mammalian cell cycle progression and for the maintenance of genomic stability, most likely by monomethylating histone H4K20.
Cell cycle analysis after synchronization indicated that defects at the S and G(2)/M phases were a consequence of decreased H4K20me1 due to the absence of PR-Set7.
Protein-lysine N-methyltransferase that monomethylates both histones and non-histone proteins. Specifically monomethylates 'Lys-20' of histone H4 (H4K20me1). H4K20me1 is enriched during mitosis and represents a specific tag for epigenetic transcriptional repression. Mainly functions in euchromatin regions, thereby playing a central role in the silencing of euchromatic genes. Required for cell proliferation, probably by contributing to the maintenance of proper higher order structure of DNA during mitosis. Involved in chromosome condensation and proper cytokinesis. Nucleosomes are preferred as substrate compared to free histones. Mediates monomethylation of p53/TP53 at 'Lys-382', leading to repress p53/TP53-target genes (By similarity).
, H4-K20-specific histone methyltransferase
, H4K20-specific histone methyltransferase splice variant Set8b
, N-lysine methyltransferase SETD8
, PR/SET domain containing protein 8
, PR/SET domain-containing protein 07
, SET domain-containing protein 8
, histone-lysine N-methyltransferase SETD8
, lysine N-methyltransferase 5A
, SET domain-containing 8